{"id":"ganirelix-gnrh-antagonist","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ganirelix is a GnRH antagonist that competitively binds to GnRH receptors on pituitary gonadotroph cells, rapidly suppressing LH secretion without an initial flare effect. This prevents the endogenous LH surge that would trigger ovulation prematurely during controlled ovarian hyperstimulation in fertility treatment cycles. By maintaining suppression of LH, it allows exogenous gonadotropins to control follicle development for optimal egg retrieval timing.","oneSentence":"Ganirelix blocks gonadotropin-releasing hormone (GnRH) receptors to suppress luteinizing hormone (LH) and prevent premature ovulation during assisted reproductive procedures.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:11.037Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART)"}]},"trialDetails":[{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT04983173","phase":"PHASE4","title":"INTEnsity of ovariaN Stimulation and Embryo Quality","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-11-23","conditions":"Infertility","enrollment":110},{"nctId":"NCT07409493","phase":"NA","title":"IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols","status":"RECRUITING","sponsor":"Hanoi Medical University","startDate":"2026-01-21","conditions":"Infertility (IVF Patients), Embryo Morphokinetics, Progestins Primed Ovarian Stimulation","enrollment":148},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT05847283","phase":"NA","title":"DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT","status":"RECRUITING","sponsor":"Tam Anh TP. Ho Chi Minh General Hospital","startDate":"2023-06-22","conditions":"Diminished Ovarian Reserve","enrollment":730},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT04265053","phase":"EARLY_PHASE1","title":"Human Cerebral Blood Flow Regulation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-04-12","conditions":"Cerebral Arterial Diseases","enrollment":110},{"nctId":"NCT06877429","phase":"","title":"Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Healthy","enrollment":20},{"nctId":"NCT07108621","phase":"PHASE3","title":"hCG Priming in Women With Diminished Ovarian Reserve","status":"RECRUITING","sponsor":"Kristine Loessl","startDate":"2025-09","conditions":"Infertility, Female, Ovarian Reserve, In Vitro Fertilization (IVF)","enrollment":80},{"nctId":"NCT05751252","phase":"EARLY_PHASE1","title":"Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS.","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2024-04-17","conditions":"Polycystic Ovary Syndrome","enrollment":20},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT06745466","phase":"PHASE4","title":"Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women","status":"RECRUITING","sponsor":"University of Delaware","startDate":"2024-11-15","conditions":"Estrogen, Premenopause","enrollment":30},{"nctId":"NCT06637189","phase":"PHASE4","title":"Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.","status":"NOT_YET_RECRUITING","sponsor":"Ginefiv","startDate":"2024-10-15","conditions":"Stimulation in the Ovary, Embryo, Oocyte","enrollment":144},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT04327934","phase":"EARLY_PHASE1","title":"Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome","status":"TERMINATED","sponsor":"Yale University","startDate":"2017-12-01","conditions":"Polycystic Ovary Syndrome, Hypertension","enrollment":28},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":"Infertility, Diminished Ovarian Reserve, IVF","enrollment":142},{"nctId":"NCT04414761","phase":"PHASE3","title":"Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-04","conditions":"IVF, GnRH Antagonist, PPOS","enrollment":784},{"nctId":"NCT04586686","phase":"NA","title":"Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":41},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT03767218","phase":"PHASE3","title":"Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2018-11-01","conditions":"Infertility, Female","enrollment":71},{"nctId":"NCT04108039","phase":"NA","title":"Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2019-09-25","conditions":"Infertility, IVF, Preimplantation Diagnosis","enrollment":44},{"nctId":"NCT02912988","phase":"PHASE3","title":"Letrozole in Stimulated IVF Cycles","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-03-01","conditions":"Subfertility","enrollment":900},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT04168892","phase":"","title":"Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response","status":"COMPLETED","sponsor":"Andros Day Surgery Clinic","startDate":"2019-09-20","conditions":"Ovarian Response","enrollment":160},{"nctId":"NCT03236545","phase":"NA","title":"Menopause Effects on Vascular Function","status":"COMPLETED","sponsor":"University of Delaware","startDate":"2016-07-01","conditions":"Cardiovascular Risk Factor","enrollment":48},{"nctId":"NCT03555942","phase":"NA","title":"Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2018-05-08","conditions":"Infertility","enrollment":44},{"nctId":"NCT00702624","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":"Pregnancy, Neonates","enrollment":113},{"nctId":"NCT00702546","phase":"","title":"Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"In Vitro Fertilization","enrollment":102},{"nctId":"NCT03300518","phase":"NA","title":"Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient","status":"COMPLETED","sponsor":"Reproductive & Genetic Hospital of CITIC-Xiangya","startDate":"2017-11-15","conditions":"Infertility","enrollment":552},{"nctId":"NCT04993924","phase":"PHASE4","title":"GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2021-05-01","conditions":"IVF, Ovarian Cysts","enrollment":15},{"nctId":"NCT05071339","phase":"PHASE4","title":"GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2021-04-01","conditions":"IVF","enrollment":15},{"nctId":"NCT03300960","phase":"PHASE3","title":"Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2017-10-20","conditions":"Infertility","enrollment":318},{"nctId":"NCT01614067","phase":"PHASE4","title":"Delayed Start to Ovarian Stimulation","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2012-05","conditions":"Diminished Ovarian Reserve, Infertility, In Vitro Fertilization","enrollment":30},{"nctId":"NCT04728659","phase":"PHASE4","title":"Desogestrel Versus GnRH Antagonist in IVF/ICSI","status":"UNKNOWN","sponsor":"Casa di Cura Privata Villa Mafalda","startDate":"2020-10-01","conditions":"IVF, Infertility","enrollment":165},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT04654741","phase":"PHASE4","title":"The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles","status":"UNKNOWN","sponsor":"Casa di Cura Privata Villa Mafalda","startDate":"2020-09-01","conditions":"IVF, Infertility","enrollment":396},{"nctId":"NCT03861715","phase":"","title":"Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.","status":"UNKNOWN","sponsor":"Assisting Nature","startDate":"2017-01","conditions":"Infertility, Premature Ovarian Failure","enrollment":180},{"nctId":"NCT04458454","phase":"","title":"\"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles\"","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2019-12-02","conditions":"Infertility, Reproductive Techniques, Assisted, Oocyte Maturation","enrollment":11},{"nctId":"NCT04416607","phase":"NA","title":"Corifollitropin Alpha and Ovarian Response","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-06-15","conditions":"Infertility, Female","enrollment":300},{"nctId":"NCT00589134","phase":"NA","title":"The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration","status":"COMPLETED","sponsor":"Yale University","startDate":"2006-01","conditions":"Exercise Induced Hyponatremia","enrollment":26},{"nctId":"NCT00823472","phase":"PHASE4","title":"Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)","status":"TERMINATED","sponsor":"UMC Utrecht","startDate":"2009-01","conditions":"in Vitro Fertilization, Ovulation Induction","enrollment":147},{"nctId":"NCT03477929","phase":"PHASE4","title":"Cetrorelix and Ganirelix Flexible Protocol for (IVF)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-11-15","conditions":"Infertility/Sterility","enrollment":100},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT02796105","phase":"PHASE4","title":"Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors","status":"COMPLETED","sponsor":"Fundació Privada Eugin","startDate":"2016-06","conditions":"Infertility","enrollment":232},{"nctId":"NCT02429999","phase":"PHASE2","title":"Letrozole in Assisted Reproductive Technology","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2015-04","conditions":"to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .","enrollment":80},{"nctId":"NCT00757185","phase":"EARLY_PHASE1","title":"Compromised Microcirculation in Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-02","conditions":"Polycystic Ovary Syndrome","enrollment":28},{"nctId":"NCT00756028","phase":"PHASE4","title":"Short Versus Long Protocol for IVF and IVF+ICSI","status":"COMPLETED","sponsor":"Peter Hornnes, MD, DMSc","startDate":"2009-01","conditions":"Infertility, Ovarian Hyperstimulation Syndrome, Quality of Life","enrollment":1099},{"nctId":"NCT01206803","phase":"","title":"Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-09","conditions":"Infertility, Subfertility","enrollment":294},{"nctId":"NCT02635607","phase":"NA","title":"Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol","status":"UNKNOWN","sponsor":"Chong Qing Reproducive and Genetic Institute","startDate":"2016-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT00780858","phase":"","title":"Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2008-10","conditions":"Infertility","enrollment":662},{"nctId":"NCT01669291","phase":"NA","title":"Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2012-07","conditions":"Fertility","enrollment":43},{"nctId":"NCT02046655","phase":"PHASE4","title":"Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2011-01","conditions":"Subfertility","enrollment":80},{"nctId":"NCT00823004","phase":"PHASE1, PHASE2","title":"Antagonist/Letrozole in Poor Responders","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-06","conditions":"Ovarian Stimulation","enrollment":120},{"nctId":"NCT00417066","phase":"PHASE4","title":"Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"Eugonia","startDate":"2003-09","conditions":"Infertility, Premature Ovarian Failure","enrollment":270},{"nctId":"NCT00417157","phase":"","title":"Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH","status":"COMPLETED","sponsor":"Eugonia","startDate":"2007-01","conditions":"Infertility, Premature Ovarian Failure","enrollment":135},{"nctId":"NCT00866008","phase":"PHASE4","title":"A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)","status":"TERMINATED","sponsor":"Bart CJM Fauser","startDate":"2008-10","conditions":"In Vitro Fertilization","enrollment":34},{"nctId":"NCT01888744","phase":"PHASE4","title":"Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2010-09","conditions":"Reproductive Endocrinology, Fertility, Optimal Stimulation Protocol","enrollment":120},{"nctId":"NCT00826839","phase":"PHASE4","title":"Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2009-01","conditions":"Infertility","enrollment":""},{"nctId":"NCT01636505","phase":"PHASE3","title":"The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol","status":"UNKNOWN","sponsor":"European Hospital","startDate":"2012-09","conditions":"Embryo's Genetic and Chromosomal Quality","enrollment":200},{"nctId":"NCT01218386","phase":"PHASE4","title":"Pretreatment With Estradiol Valerate","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2010-05","conditions":"Infertility","enrollment":80},{"nctId":"NCT01487486","phase":"","title":"Proteomics & Glyco-Proteomic Analysis of Follicular Fluid","status":"UNKNOWN","sponsor":"University of Cincinnati","startDate":"2011-12","conditions":"Polycystic Ovary Syndrome, Normal Volunteers","enrollment":30},{"nctId":"NCT00802360","phase":"PHASE4","title":"MENOPUR® Versus FOLLISTIM®","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2008-12","conditions":"Infertility","enrollment":173},{"nctId":"NCT01424618","phase":"NA","title":"A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs","status":"UNKNOWN","sponsor":"Kelly, Maureen, M.D.","startDate":"2006-01","conditions":"Implantation, Embryo","enrollment":20},{"nctId":"NCT00434122","phase":"PHASE2","title":"Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-03","conditions":"Infertility, Female","enrollment":85},{"nctId":"NCT00985062","phase":"NA","title":"Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2004-10","conditions":"Subfertility","enrollment":54},{"nctId":"NCT00830492","phase":"PHASE4","title":"Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-01","conditions":"Ovarian Stimulation","enrollment":200},{"nctId":"NCT00823602","phase":"PHASE3","title":"Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH","status":"UNKNOWN","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-03","conditions":"Infertility","enrollment":2},{"nctId":"NCT00461422","phase":"PHASE4","title":"Early Follicular Supplementation of Ganirelix in IVF 2004","status":"COMPLETED","sponsor":"The Baruch Padeh Medical Center, Poriya","startDate":"2004-01","conditions":"Infertility, IVF Treatment","enrollment":50},{"nctId":"NCT00635258","phase":"","title":"Administration of GnRH Antagonist to Oocyte Donation Recipients","status":"COMPLETED","sponsor":"Centro Ginecologia y Obstetricia.","startDate":"2004-01","conditions":"Pregnancy, Embryo Implantation","enrollment":100},{"nctId":"NCT00417183","phase":"PHASE4","title":"Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2005-09","conditions":"Infertility","enrollment":300},{"nctId":"NCT00417144","phase":"PHASE4","title":"Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2003-11","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":187,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Ganirelix (GnRH antagonist)","genericName":"Ganirelix (GnRH antagonist)","companyName":"Instituto Valenciano de Infertilidad, IVI VALENCIA","companyId":"instituto-valenciano-de-infertilidad-ivi-valencia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ganirelix blocks gonadotropin-releasing hormone (GnRH) receptors to suppress luteinizing hormone (LH) and prevent premature ovulation during assisted reproductive procedures. Used for Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}